1. Home
  2. BIOX vs PLUR Comparison

BIOX vs PLUR Comparison

Compare BIOX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.35

Market Cap

23.0M

Sector

Industrials

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$1.84

Market Cap

25.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
PLUR
Founded
2001
2001
Country
Argentina
Israel
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
25.5M
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
BIOX
PLUR
Price
$0.35
$1.84
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.33
$12.00
AVG Volume (30 Days)
98.7K
26.3K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
$37.82
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$0.30
$1.45
52 Week High
$3.25
$5.68

Technical Indicators

Market Signals
Indicator
BIOX
PLUR
Relative Strength Index (RSI) 50.18 47.43
Support Level $0.31 $1.51
Resistance Level $0.40 $2.01
Average True Range (ATR) 0.04 0.11
MACD 0.00 0.04
Stochastic Oscillator 55.88 64.34

Price Performance

Historical Comparison
BIOX
PLUR

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: